Red Nucleus (RN) / Riverside Acquire AlphaGroup Medical Communications
December 12, 2022
Red Nucleus (RN), a portfolio company of The Riverside Company, has acquired AlphaGroup Medical Communications, LLC as an add-on to RN's medical communications business unit. The acquisition expands RN's publications, medical affairs and HEOR/RWE capabilities and brings AlphaGroup's therapeutic expertise and scientific staff into the combined business.
- Buyers
- Red Nucleus (RN), The Riverside Company
- Targets
- AlphaGroup Medical Communications, LLC
- Platforms
- Red Nucleus (RN)
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Red Nucleus / Riverside Acquire INVIVO Communications
September 30, 2020
Healthcare Services
Red Nucleus, the life-sciences learning and performance platform backed by The Riverside Company, acquired Toronto-based INVIVO Communications, a digital scientific communications agency. The deal is an add-on to Riverside's Red Nucleus platform, expanding RN's medical communications and digital scientific communications capabilities; the combined business now totals 360+ employees across seven locations.
-
The Riverside Company Acquires Red Nucleus from Renovus Capital Partners
March 24, 2020
Education
The Riverside Company has acquired Red Nucleus Enterprises, LLC, a Yardley, Pennsylvania-based provider of digital learning and regulatory compliance services for the life sciences industry. Renovus Capital Partners sold the company to Riverside but retained a minority equity stake and will continue to support future growth; Riverside plans to expand Red Nucleus's training offerings, technology capabilities and pursue add-on acquisitions.
-
THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company
October 17, 2024
Healthcare Services
THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.
-
Red Nucleus Acquires Medical Marketing Solutions Group (MMSG)
February 9, 2022
Healthcare Services
Red Nucleus, a Riverside-backed medical communications and scientific services provider, acquired Medical Marketing Solutions Group (MMSG) in February 2022 to expand its medical communications, publication planning, and conference management capabilities. The acquisition was completed as an add-on to the Red Nucleus platform, owned by The Riverside Company, broadening Red Nucleus’s therapeutic-area coverage and client relationships within biopharma.
-
Red Nucleus / Riverside Invests in Human Element Solutions (element H)
February 21, 2023
Healthcare Services
Red Nucleus (RN), backed by The Riverside Company, acquired Human Element Solutions, LLC (element H) in February 2023 as an add-on to the RN platform. The acquisition brings element H's meeting and event production, creative communications, video and digital content capabilities into RN's learning & development business to expand services for biotech, pharmaceutical and medical device customers.
-
Red Nucleus Acquires Bridge Medical Consulting
February 5, 2026
Healthcare Services
Red Nucleus has acquired Bridge Medical Consulting, a UK-based health economics and outcomes research (HEOR) consultancy, to broaden its HEOR, real-world evidence, and market access capabilities for biopharmaceutical clients. The firm will be merged into Red Nucleus's existing HEOR business to expand evidence synthesis, economic modeling, RWE research, and AI-enabled workflows.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.